Cite
HARVARD Citation
Chen, H. et al. (2020). JAK1/2 pathway inhibition suppresses M2 polarization and overcomes resistance of myeloma to lenalidomide by reducing TRIB1, MUC1, CD44, CXCL12, and CXCR4 expression. British journal of haematology. pp. 283-294. [Online].